http://www.fpnotebook.com/
LamotrigineAka: Lamictal
- Indications
- Adverse Effects: Dose related
- Adverse Effects: Other
- Steven's Johnson Syndrome
- Aplastic Anemia
- Thrombocytopenia
- Neutropenia
- Pancytopenia
- Drug Interactions
- Antiepileptic agents (especially Valproic Acid)
- Dosing: Adults
- Initial: 25 mg every other day for 2 weeks
- Next: 25 mg PO qd for 2 weeks
- Target dose: 50-100 mg PO bid
- Maximum dose: 400 mg/day
lamotrigine (C0064636) | |
|---|---|
| Definition (PDQ) | A synthetic phenyltriazine with antiepileptic and analgesic properties. Lamotrigine enhances the action of gamma-aminobutyric acid, an inhibitory neurotransmitter, which may result in a reduction of pain-related transmission of signals along nerve fibers. This agent may also inhibit voltage-gated sodium channels, suppress glutamate release, and inhibit serotonin reuptake. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=328241&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=328241&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C38703" NCI Thesaurus) |
| Definition (NCI) | A synthetic phenyltriazine with antiepileptic and analgesic properties. Lamotrigine enhances the action of gamma-aminobutyric acid, an inhibitory neurotransmitter, which may result in a reduction of pain-related transmission of signals along nerve fibers. This agent may also inhibit voltage-gated sodium channels, suppress glutamate release, and inhibit serotonin reuptake. (NCI04) |
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | C047781 |
| English | lamotrigine, LAMOTRIGINE PREPARATION |
| Spanish | lamotrigina |
| Parent Concepts | Anticonvulsants (C0003286), Triazines (C0040877), Phenyltriazine derivative anticonvulsant (C1445641), Glutamate Reducing Agents (C1579355) |
| Sources | CSP, LNC, MSH, MTHSPL, NCI, NDFRT, PDQ, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
Lamictal (C0678180) | |
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | C047781 |
| English | Desitin Brand of Lamotrigine, Glaxo Wellcome Brand of Lamotrigine, GlaxoSmithKline Brand of Lamotrigine, Lamictal, Lamiktal |
| Sources | MSH, MTH, NCI, PDQ, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
